(NASDAQ:LAMR), BATON ROUGE, La., Jan. 21, 2025 (GLOBE NEWSWIRE) — Lamar Advertising Company (“Lamar”) (Nasdaq: LAMR) today announced certain year-end federal income tax reporting information for its 2024 distributions on its Class A and Class B common stock (“Common Stock”). The following table summarizes, for federal income tax purposes, the nature of distributions paid to […]
(NYSE:BC), METTAWA, Ill., Jan. 21, 2025 (GLOBE NEWSWIRE) — Dave Foulkes, Chief Executive Officer of Brunswick Corporation, has been named to Crain's Chicago Business 2025 Who's Who list for the second consecutive year. This prestigious annual feature highlights over 400 of Chicago's most influential leaders across diverse industries, including business, art, government, healthcare, cultural institutions,
ROAD TOWN, British Virgin Islands, Jan. 21, 2025 (GLOBE NEWSWIRE) — Aspis is revolutionizing decentralized finance (DeFi) by combining the power of artificial intelligence (AI) with the decentralized, transparent, and secure framework of DeFi. Our innovative platform empowers users to achieve their financial goals without requiring technical expertise. Aspis simplifies asset management, making it accessible
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of AstraZeneca PLC (NASDAQ: AZN) publicly traded securities between February 23, 2022 and December 17, 2024, inclusive (the “Class Period”), have until Friday, February 21, 2025 to seek appointment as lead plaintiff of the AstraZeneca class action lawsuit. CaptionedSaleh v.
— IFEZ's 'INCHEON-IFEZ' Booth attracts 12,000 visitors — Participating companies secure a foundation for global expansion, including 10 MoU signings TheIncheon Free Economic Zone Authority (IFEZ) has announced that the 'INCHEON-IFEZ' booth at CES 2025 showcased its vision for the future of smart cities and promoted innovative companies from Incheon to a global audience. https://mma.prnewswire.com/media/2602344/photo.jpg
Levi &Korsinsky, LLP notifies investors in Kyverna Therapeutics, Inc. (“Kyverna Therapeutics, Inc.” or the “Company”) (NASDAQ: KYTX) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Kyverna Therapeutics, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all those
Levi & Korsinsky, LLP notifies investors in Symbotic Inc. (“Symbotic” or the “Company”) (NASDAQ: SYM) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Symbotic investors who were adversely affected by alleged securities fraud between February 8, 2024 and November 26, 2024. Follow the link below
Levi &Korsinsky, LLP notifies investors in ASP Isotopes Inc. (“ASP Isotopes Inc.” or the “Company”) (NASDAQ: ASPI) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ASP Isotopes Inc. investors who were adversely affected by alleged securities fraud between October 30, 2024 and November 26, 2024.
Levi &Korsinsky, LLP notifies investors in Five9, Inc. (“Five9, Inc.” or the “Company”) (NASDAQ: FIVN) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Five9, Inc. investors who were adversely affected by alleged securities fraud between June 4, 2024 and August 8, 2024. Follow the link
Levi & Korsinsky, LLP notifies investors in Aehr Test Systems, Inc. (“Aehr” or the “Company”) (NASDAQ: AEHR) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Aehr investors who were adversely affected by alleged securities fraud between January 9, 2024 and March 24, 2024. Follow the